What’s New
Prof. Pellegata and Dr. Isabella Fabietti attended the EUPSA 2026 Congress in Vienna. It was a great opportunity to connect with clinicians, researchers, and collaborators working in pediatric surgery and regenerative medicine, exchange ideas, and discuss the latest advances in the field. We are excited to bring back new inspiration, perspectives, and potential collaborations for our ongoing projects.
We had the pleasure of attending TERMIS-EU 2026 in Palma de Mallorca. It was a great opportunity to meet old and new friends and learn about the latest advances in tissue engineering and regenerative medicine. We had the opportunity to present the latest updates on our projects. Looking forward to turning these insights into new experiments, collaborations, and projects.
We are excited to have contributed to this Nature Biotechnology publication on the first engineered autologous graft of the esophagus in a large-animal model. A huge thank you to Dr. Pellegrini and Prof. De Coppi – we are proud to be part of this important advancement.
We are thrilled to share that we contributed to a publication in collaboration with the Gerli Lab, which has been featured on the cover of Nature Protocols! The work focuses on the development and characterization of amniotic fluid-derived organoids, representing an important step forward in fetal therapy research. Read the full paper here.
An interview has been published on Osservatorio Malattie Rare, an Italian platform dedicated to raising awareness and sharing research on rare diseases, about the ERC Proof-of-Concept PROTECT project focused on drug safety during pregnancy. The interview highlights the project’s objectives and its expected impact on supporting safer, evidence-based treatments for pregnant women. Read the full article here.
We’re excited to announce that our lab has been awarded an ERC Proof of Concept grant. PROTECT aims to tackle the lack of knowledge around therapeutic choices during pregnancy by developing a 3D bioprinted model to assess fetal drug toxicity, helping to support safer, evidence-based treatments for pregnant women.
Prof. Pellegata and Carlotta had a great time attending the Nature Conference: Engineered Models of Human Disease in Belgrade this October. It was a fantastic chance to catch up with our friends and collaborators from UCL, enjoy inspiring talks, and make the most of Belgrade’s amazing food and atmosphere.
Carlotta and Alessandro took part in the XLIV GNB Annual School, where they had the chance to meet biomedical engineers from all over Italy and exchange ideas.
We were present at the 20th edition of the Computational Intelligence Methods for Bioinformatics and Biostatistics, held at our home Politecnico di Milano. Alessandro had the opportunity to present a poster and share his research with the community.
We are excited to have contributed to this Nature Protocols publication on deriving amniotic fluid organoids (AFOs)! A huge thank you to Prof. Gerli and Prof. De Coppi – we’re thrilled to see our collaboration continue to grow and make an impact.
We attended the MaxQuant Summer School 2025 in Utrecht! Alessandro boosted his expertise in mass spectrometry techniques and proteomics data analysis. He also had the opportunity to present his research on transcriptomic characterization of the amniotic fluid.
